Terms: = Ovarian cancer AND TNFRSF17, BCMA, 608, ENSG00000048462, CD269, Q02223, BCM AND Staging
4 results:
1. Fusion imaging in preoperative assessment of extent of disease in patients with advanced ovarian cancer: feasibility and agreement with laparoscopic findings.
Moro F; Bertoldo V; Avesani G; Moruzzi MC; Mascilini F; Bolomini G; Caliolo G; Esposito R; Moroni R; Zannoni GF; Fagotti A; Manfredi R; Scambia G; Testa AC
Ultrasound Obstet Gynecol; 2021 Dec; 58(6):916-925. PubMed ID: 33847427
[TBL] [Abstract] [Full Text] [Related]
2. Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials.
Vergote I; Coens C; Nankivell M; Kristensen GB; Parmar MKB; Ehlen T; Jayson GC; Johnson N; Swart AM; Verheijen R; McCluggage WG; Perren T; Panici PB; Kenter G; Casado A; Mendiola C; Stuart G; Reed NS; Kehoe S; ;
Lancet Oncol; 2018 Dec; 19(12):1680-1687. PubMed ID: 30413383
[TBL] [Abstract] [Full Text] [Related]
3. Transperitoneal
Prodromidou A; Machairas N; Spartalis E; Kostakis ID; Iavazzo C; Moris D; Tsilimigras DI; Athanasiou A; Nikiteas N
Anticancer Res; 2018 Aug; 38(8):4677-4681. PubMed ID: 30061235
[TBL] [Abstract] [Full Text] [Related]
4. Mean nuclear volume in ovarian papillary serous cystadenocarcinoma.
Mohanty SK; Dey P; Saha SC
Anal Quant Cytol Histol; 2004 Feb; 26(1):28-30. PubMed ID: 15032078
[TBL] [Abstract] [Full Text] [Related]
